These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1776591)

  • 21. Kinetic-dynamic relationship of oral levodopa: possible biphasic response after sequential doses in Parkinson's disease.
    Contin M; Riva R; Martinelli P; Baruzzi A
    Mov Disord; 1992; 7(3):244-8. PubMed ID: 1620142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of early Parkinson's disease with controlled-release levodopa preparations.
    Rinne UK; Rinne JO
    Neurology; 1989 Nov; 39(11 Suppl 2):78-81; discussion 95. PubMed ID: 2586766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].
    Eichhorn TE; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel WH; Poewe W
    Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.
    Leufkens TR; Vermeeren A
    J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.
    Block G; Liss C; Reines S; Irr J; Nibbelink D
    Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Euhypnos Forte (temazepam) for resistant insomnia: post-marketing surveillance, an interim report.
    Fowler LK
    J Int Med Res; 1979; 7(5):379-82. PubMed ID: 40839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlormethiazole--no hangover effect but not an ideal hypnotic for the young.
    Castleden CM; George CF; Sedgwick EM
    Postgrad Med J; 1979 Mar; 55(641):159-60. PubMed ID: 379841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease.
    Rocha JF; Ferreira JJ; Falcão A; Santos A; Pinto R; Nunes T; Almeida L; Soares-da-Silva P
    Clin Pharmacol Drug Dev; 2016 May; 5(3):232-40. PubMed ID: 27163503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind evaluation of the efficacy and safety of temazepam in outpatients with insomnia.
    Fillingim JM
    Br J Clin Pharmacol; 1979; 8(1):73S-77S. PubMed ID: 41546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease.
    Ferreira JJ; Rocha JF; Falcão A; Santos A; Pinto R; Nunes T; Soares-da-Silva P
    Eur J Neurol; 2015 May; 22(5):815-25, e56. PubMed ID: 25649051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlormethiazole and temazepam.
    Swift CG; Haythorne JM; Clarke P; Stevenson IH
    Br Med J; 1980 May; 280(6227):1322. PubMed ID: 6104531
    [No Abstract]   [Full Text] [Related]  

  • 32. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.
    Olanow CW; Fahn S; Muenter M; Klawans H; Hurtig H; Stern M; Shoulson I; Kurlan R; Grimes JD; Jankovic J
    Mov Disord; 1994 Jan; 9(1):40-7. PubMed ID: 8139604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspects of driving after hypnotic therapy with particular reference to temazepam.
    Schmidt U; Brendemühl D; Rüther E
    Acta Psychiatr Scand Suppl; 1986; 332():112-8. PubMed ID: 2883818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Slow-release L-dopa vs. standard L-dopa in Parkinson patients in various stages of the disease. Studies of pharmacokinetics and motor effectiveness].
    Bergemann N; Baas H; Fischer PA
    Nervenarzt; 1994 Apr; 65(4):250-7. PubMed ID: 8015632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of lormetazepam and chlormethiazole in elderly in-patients.
    Overstall PW; Oldman PN
    Age Ageing; 1987 Jan; 16(1):45-51. PubMed ID: 3551551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse effects of temazepam in older adults with chronic insomnia.
    Morin CM; Bastien CH; Brink D; Brown TR
    Hum Psychopharmacol; 2003 Jan; 18(1):75-82. PubMed ID: 12532318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
    Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
    Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.
    Diamond SG; Markham CH; Treciokas LJ
    Ann Neurol; 1978 Mar; 3(3):267-72. PubMed ID: 352236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of chlormethiazole in EEG recorded sleep in normal elderly volunteers.
    Liljenberg B; Almqvist M; Broman JE; Hetta J; Roos BE
    Acta Psychiatr Scand Suppl; 1986; 329():34-9. PubMed ID: 3463156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temazepam withdrawal in elderly hospitalized patients: a double blind randomised trial comparing abrupt versus gradual withdrawal.
    Tham TC; Brown H; Taggart HM
    Ir J Med Sci; 1989 Dec; 158(12):294-9. PubMed ID: 2576423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.